Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Lymphoma, Follicular 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma 5Neoplasms 3Multiple Myeloma 3COVID-19 3Opioid-Related Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Sezary Syndrome 1Recurrence 1Obesity 1Neurologic Manifestations 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Genital Neoplasms, Female 1Dementia 1Criminal Behavior 1Colorectal Neoplasms 1Cognitive Dysfunction 1Breast Neoplasms 1Anomia 1Alzheimer Disease 1

Interventions

Methods 2Electroencephalography 2mazdutide 1fasudil 1blueberry extract 1Walking 1Tablets 1Standard of Care 1Rehabilitation, Vocational 1Referral and Consultation 1Hormones 1Exercise 1Employment, Supported 1Drug Delivery Systems 1Control Groups 1Accidental Falls 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Standard of Care × Lymphoid × Clear all
NCT05894954 2026-02-18

EVANTHEA

Alzheimer's Prevention and Reversal Project, Inc.

Phase 3 Completed
73 enrolled
Lymphoid

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡